Consistent with this finding, BC cells with PAR3 deficiency demonstrate mislocalization and activation of aPKC with MMP9 (matrix metallopeptidase 9) activation to digest the extracellular matrix for tumor invasion and metastasis [41]. Here, MMP9 is linked to breast cancer.